aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ATYR is expected to report earnings to rise 14.82% to -12 cents per share on August 12
Q2'26
Est.
$-0.13
Q1'26
Beat
by $0.03
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.09
Q2'25
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -10 cents, beating the estimate of -13 cents. With 1.35M shares outstanding, the current market capitalization sits at 46.10M.